CamBioLogics was founded in Cambridge, United Kingdom, by a team of experienced biologists and life-science experts with deep backgrounds in genetics, antibody research, and biotechnology.
The company was born from a shared observation: while biological data has grown exponentially, traditional research methods struggle to keep pace with its complexity. Recognising the transformative potential of artificial intelligence, the founders set out to build a company that could bridge advanced biology with intelligent computation.
From its inception, CamBioLogics has focused on applying AI-driven approaches to core biological challenges—from understanding genetic variation to accelerating antibody discovery and optimisation. By combining rigorous biological science with modern machine-learning techniques, the team aims to shorten discovery timelines and enable more precise, data-driven decisions across the biotech pipeline.
Rooted in Cambridge's globally recognised life-science ecosystem, CamBioLogics continues to grow as a research-driven, innovation-focused biotech company, collaborating with academic and industry partners to translate AI-powered biology into meaningful scientific and commercial impact.
